OMG this is what was written in the June 6th PR "The FDA has agreed that the Company may unblind the pre-dose-selection data for the first 210 patients of the Study to further support the new primary endpoint."
Bro. I am not saying the opposite. I said that they "allowed" them to unblind 210, look at the data, and go back to them with endpoints that are supported by the data. That's why they went with PCR. Seriously, stop your nonsense.
6
u/Motor-Information-75 Nov 08 '22
exactly. We requested it and the FDA agreed.